1. Home
  2. HALO vs ROAD Comparison

HALO vs ROAD Comparison

Compare HALO & ROAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • ROAD
  • Stock Information
  • Founded
  • HALO 1998
  • ROAD 2001
  • Country
  • HALO United States
  • ROAD United States
  • Employees
  • HALO N/A
  • ROAD N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • ROAD Engineering & Construction
  • Sector
  • HALO Health Care
  • ROAD Industrials
  • Exchange
  • HALO Nasdaq
  • ROAD Nasdaq
  • Market Cap
  • HALO 7.6B
  • ROAD 6.9B
  • IPO Year
  • HALO N/A
  • ROAD 2018
  • Fundamental
  • Price
  • HALO $76.90
  • ROAD $125.20
  • Analyst Decision
  • HALO Buy
  • ROAD Buy
  • Analyst Count
  • HALO 8
  • ROAD 3
  • Target Price
  • HALO $70.25
  • ROAD $112.33
  • AVG Volume (30 Days)
  • HALO 2.0M
  • ROAD 478.0K
  • Earning Date
  • HALO 10-30-2025
  • ROAD 08-07-2025
  • Dividend Yield
  • HALO N/A
  • ROAD N/A
  • EPS Growth
  • HALO 68.93
  • ROAD 2.44
  • EPS
  • HALO 4.37
  • ROAD 1.37
  • Revenue
  • HALO $1,178,672,000.00
  • ROAD $2,450,670,000.00
  • Revenue This Year
  • HALO $32.57
  • ROAD $55.82
  • Revenue Next Year
  • HALO $23.25
  • ROAD $17.07
  • P/E Ratio
  • HALO $17.65
  • ROAD $91.69
  • Revenue Growth
  • HALO 34.97
  • ROAD 39.18
  • 52 Week Low
  • HALO $42.01
  • ROAD $61.31
  • 52 Week High
  • HALO $77.60
  • ROAD $125.70
  • Technical
  • Relative Strength Index (RSI)
  • HALO 77.94
  • ROAD 63.89
  • Support Level
  • HALO $74.52
  • ROAD $119.47
  • Resistance Level
  • HALO $76.28
  • ROAD $123.90
  • Average True Range (ATR)
  • HALO 1.63
  • ROAD 3.45
  • MACD
  • HALO -0.06
  • ROAD 0.14
  • Stochastic Oscillator
  • HALO 88.60
  • ROAD 95.33

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

Share on Social Networks: